DE3361453D1 - 9-dihydro-11,12-ketal derivatives of erythromycin a and epi-erythromycin a - Google Patents
9-dihydro-11,12-ketal derivatives of erythromycin a and epi-erythromycin aInfo
- Publication number
- DE3361453D1 DE3361453D1 DE8383300937T DE3361453T DE3361453D1 DE 3361453 D1 DE3361453 D1 DE 3361453D1 DE 8383300937 T DE8383300937 T DE 8383300937T DE 3361453 T DE3361453 T DE 3361453T DE 3361453 D1 DE3361453 D1 DE 3361453D1
- Authority
- DE
- Germany
- Prior art keywords
- erythromycin
- epi
- dihydro
- ketal derivatives
- ketal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1
- 229960003276 erythromycin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/353,548 US4382086A (en) | 1982-03-01 | 1982-03-01 | 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3361453D1 true DE3361453D1 (en) | 1986-01-23 |
Family
ID=23389607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8383300937T Expired DE3361453D1 (en) | 1982-03-01 | 1983-02-23 | 9-dihydro-11,12-ketal derivatives of erythromycin a and epi-erythromycin a |
Country Status (8)
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8421429D0 (en) * | 1984-08-23 | 1984-09-26 | Beecham Group Plc | Chemical compounds |
EP0184921A3 (en) * | 1984-12-08 | 1986-10-29 | Beecham Group Plc | Erythromycin derivatives |
DK109886A (da) | 1985-03-12 | 1986-09-13 | Beecham Group Plc | Erythromycinderivater |
US4640910A (en) * | 1985-11-12 | 1987-02-03 | Abbott Laboratories | Erythromycin A silylated compounds and method of use |
US4681872A (en) * | 1985-11-12 | 1987-07-21 | Abbott Laboratories | Erythromycin A 11,12-carbonate and method of use |
WO1992006991A1 (fr) * | 1990-10-15 | 1992-04-30 | Taisho Pharmaceutical Co., Ltd. | Erythromycine modifiee en 2' ou derive de cette substance |
US20040005641A1 (en) * | 2002-02-15 | 2004-01-08 | Michael Burnet | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
HRP20040850A2 (en) * | 2002-02-15 | 2005-08-31 | Synovo Gmbh | Conjugates of biologically active compounds, methods for their preparation and use formulation and pharmaceutical applications thereof |
US7271154B2 (en) * | 2002-02-15 | 2007-09-18 | Merckle Gmbh | Antibiotic conjugates |
DE60325377D1 (de) * | 2002-08-29 | 2009-01-29 | Pfizer | Motilidverbindungen |
US7211568B2 (en) * | 2003-12-18 | 2007-05-01 | Kosan Biosciences Incorporated | 9-Desoxoerythromycin compounds as prokinetic agents |
JP2009502838A (ja) * | 2005-07-26 | 2009-01-29 | メルクレ,ゲーエムベーハー | ピロリジンおよびインドリジン化合物のマクロライド接合体 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2653899A (en) * | 1952-04-14 | 1953-09-29 | Lilly Co Eli | Erythromycin, its salts, and method of preparation |
US3417077A (en) * | 1966-05-16 | 1968-12-17 | Lilly Co Eli | Erythromycin derivative and process for the preparation thereof |
US3884904A (en) * | 1973-06-21 | 1975-05-20 | Abbott Lab | 11-Substituted erythromycin B derivatives |
US3884903A (en) * | 1973-06-21 | 1975-05-20 | Abbott Lab | 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives |
US4150220A (en) * | 1977-02-04 | 1979-04-17 | Pfizer Inc. | Semi-synthetic 4"-erythromycin A derivatives |
-
1982
- 1982-03-01 US US06/353,548 patent/US4382086A/en not_active Expired - Lifetime
-
1983
- 1983-02-23 EP EP83300937A patent/EP0087916B1/en not_active Expired
- 1983-02-23 DE DE8383300937T patent/DE3361453D1/de not_active Expired
- 1983-02-23 GR GR70583A patent/GR77921B/el unknown
- 1983-02-25 YU YU459/83A patent/YU42841B/xx unknown
- 1983-02-28 DK DK096983A patent/DK159853C/da not_active IP Right Cessation
- 1983-02-28 IE IE410/83A patent/IE54431B1/en not_active IP Right Cessation
- 1983-03-01 JP JP58033682A patent/JPS58159500A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH0142275B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1989-09-11 |
EP0087916A1 (en) | 1983-09-07 |
US4382086A (en) | 1983-05-03 |
YU42841B (en) | 1988-12-31 |
IE54431B1 (en) | 1989-10-11 |
DK96983A (da) | 1983-09-02 |
DK159853B (da) | 1990-12-17 |
YU45983A (en) | 1986-02-28 |
EP0087916B1 (en) | 1985-12-11 |
DK159853C (da) | 1991-05-13 |
DK96983D0 (da) | 1983-02-28 |
JPS58159500A (ja) | 1983-09-21 |
GR77921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-09-25 |
IE830410L (en) | 1983-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS57158798A (en) | Novel erythromycin a derivative, manufacture and use | |
ZA866443B (en) | Erythromycin derivatives | |
GB8410727D0 (en) | Azet-2-one derivatives | |
GB8300400D0 (en) | 5-methylthiopyrimidine derivatives | |
GB2128188B (en) | Propynylaminoisoxazole derivatives | |
EP0096296A3 (en) | 1-sulfo-2-oxoazetidine derivatives | |
HK30486A (en) | Halogenbiphenyl derivatives | |
DE3263164D1 (en) | Erythromycin b derivatives | |
ZA841592B (en) | Macrolide derivatives | |
DE3377576D1 (en) | C-20-modified macrolide derivatives | |
DE3361453D1 (en) | 9-dihydro-11,12-ketal derivatives of erythromycin a and epi-erythromycin a | |
GB2135670B (en) | C-20- and c-23-modified macrolide derivatives | |
EP0100250A3 (en) | Methylflavone derivatives | |
GB2132617B (en) | Propynlaminothiazole derivatives | |
DE3263301D1 (en) | Erythromycin a derivatives | |
GB8330016D0 (en) | 2-piperazinyl-quinazoline derivatives | |
GB2123815B (en) | Aletheine derivatives | |
GB2124215B (en) | Eburnane-oxime derivatives | |
GB2131803B (en) | Oxacephalosporin derivatives | |
PH16669A (en) | Erythromycylamine 11,12-carbonate and derivatives thereof | |
DE3468883D1 (en) | Macrolide derivatives | |
ZA841277B (en) | C-20-and c-23-modified macrolide derivatives | |
GB2121786B (en) | 23-demycinosyldesmycosin derivatives | |
GB2116170B (en) | 23-0-acyl-23-demycinosyldesmycosin derivatives | |
GB8326187D0 (en) | 15-cycloaliphatic derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |